Merck Serono's new and improved version of its blockbuster multiple
sclerosis (MS) drug Rebif (interferon beta-1a) has been approved in
the EU, providing a little added protection to the company's MS
franchise.
Researchers in Scotland have successfully bred five generations of
transgenic hens producing therapeutic proteins in the whites of
their eggs. This latest news takes the field a step closer to
establishing transgenic flocks that could...
Oxford Biomedica and Viragen have announced a breakthrough in
transgenic research in which scientists have successfully achieved
expression of significant quantities of a human protein in hens
that is a key component of the human...
Serono of Switzerland is planning to expand its billion dollar
multiple sclerosis franchise with a new version of interferon beta
that would do away with the need for injections, reports Phil
Taylor.
The resurgence of merger and acquisition activity in the biotech
industry shows little sign of letting up, with US companies IDEC
Pharmaceuticals and Biogen the latest to step up to the altar
